Concept for feasibility review
Comprehensive Brain & Nerve Support Tablets
TabletBrain & Cognitive
Preliminary source description
An advanced brain health formula with Ginkgo biloba, amino acids, Co-Q10, and essential nutrients to support cognitive function and mental performance.
Proposed benefit themes
Themes for assessment only; they are not approved label claims.
BrainEnergy
Preliminary source ingredients
Ingredients: Ginkgo Biloba Extract (24% Flavones) 120 mg, 5-HTP 20 mg, L-Arginine 40 mg, Glutamine 10 mg, L-Glutathione 5 mg, Co-Q10 10 mg, Phosphatidylserine (20%) 10 mg, Phosphatidylcholine 10 mg, Natural Mixed Carotenoids (20%) 2 mg, Vitamin D (as D3 1000 IU) 25 mcg, Vitamin E (50% Acetate 40 IU) 36 mg, Vitamin C 40 mg, Vitamin B1 (Thiamin) 25 mg, Vitamin B2 (Riboflavin) 3 mg, Vitamin B3 (Niacin) 32 mg, Vitamin B6 (as Pyridoxine Hydrochloride) 10 mg, Folic Acid 400 mcg, Vitamin B12 (Cyanocobalamin) 100 mcg, Vitamin B5 (as Calcium-d-Pantothenate) 36 mg, Magnesium (as Magnesium Oxide) 75 mg, Iron (as Ferrous Fumarate) 8 mg, Zinc (as Zinc Sulfate) 15 mg, Manganese (as Manganese Sulphate) 2 mg, Copper (as Cupric Sulphate) 250 mcg, Selenium (as Sodium Selenite) 110 mcg, Chromium (as Chromium Picolinate) 40 mcg, Iodine (as Potassium Iodide) 150 mcg. Other Ingredients: Dibasic Calcium Phosphate, Maize Starch, Croscarmellose Sodium, Crospovidone, Povidone, Magnesium Stearate, Purified Talc, Colloidal Silicon Dioxide.
Preliminary source directions
Not final Canadian directions for use.
One Tablet per day with your main meal. Swallow with water or cold drink. Not to be chewed. Do not exceed the recommended int
Illustrative market reference
Neuriva
This unaffiliated reference is included only to illustrate a possible market category. Nostrum Health is not affiliated with, endorsed by, or representing the referenced brand, and no equivalence is implied.
Assess this concept for your project
Tell us your market, target format, quantities, timing, and current regulatory status. We will scope the commercial and regulatory feasibility review.